Table 2.

Terminal plasma glucose, total cholesterol or triglycerides of non‐fasted DIO rats at termination after 28 days of vehicle or drug treatment

Cohort	Drug treatment	Plasma glucose (mg dL−1)	Cholesterol (mg dL−1)	Triglycerides (mg dL−1)
Cohort 1	Vehicle	156 ± 3	123 ± 6	238 ± 44
	Amylin	149 ± 5	106 ± 8	132 ± 17
	Leptin	152 ± 4	116 ± 11	166 ± 46
	Amylin/leptin	153 ± 3	109 ± 7	110 ± 26
Cohort 2	Vehicle	163 ± 4	121 ± 12	224 ± 41
	Amylin	155 ± 4	102 ± 3	129 ± 27
	Leptin	154 ± 3	94 ± 3	213 ± 24
	Amylin/leptin	151 ± 4	110 ± 8	142 ± 24
Cohort 3	Vehicle	155 ± 5	112 ± 13	185 ± 28
	Amylin	162 ± 10	94 ± 5	139 ± 33
	Leptin	147 ± 1	113 ± 5	182 ± 32
	Amylin/leptin	149 ± 4	100 ± 8	127 ± 22